Invenomic Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
The RMR Group
RMR
|
+$4.54M |
| 2 |
InterDigital
IDCC
|
+$4.48M |
| 3 |
Stride
LRN
|
+$4.07M |
| 4 |
Strategy Inc
MSTR
|
+$2.79M |
| 5 |
Valvoline
VVV
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JetBlue
JBLU
|
+$6.96M |
| 2 |
SAVE
Spirit Airlines, Inc.
SAVE
|
+$5.53M |
| 3 |
Bausch Health
BHC
|
+$4.16M |
| 4 |
Raymond James Financial
RJF
|
+$4.11M |
| 5 |
Applied Industrial Technologies
AIT
|
+$3.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.23% |
| 2 | Consumer Discretionary | 15.57% |
| 3 | Industrials | 12.32% |
| 4 | Healthcare | 9.67% |
| 5 | Communication Services | 7.24% |
Similar funds
Invenomic Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Invenomic Capital Management held 188 positions worth $122M, down 51% from $249M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Invenomic Capital Management withdrew a net $58.3M in Q1 2020, closing 36 positions and reducing 68 holdings. Its most notable exit was JetBlue, an estimated $6.96M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Invenomic Capital Management opened a new position in The RMR Group worth $3.16M.
- Invenomic Capital Management's largest Q1 2020 buy was The RMR Group: 117,245 shares worth $3.16M.
- Invenomic Capital Management added most to UGI in Q1 2020, an estimated $1.26M increase.
- Invenomic Capital Management's biggest Q1 2020 reduction was Bausch Health, cutting an estimated $4.16M.
- Invenomic Capital Management fully exited JetBlue in Q1 2020, selling an estimated $6.96M.
- Invenomic Capital Management's ten largest holdings make up 25% of its $122M portfolio in Q1 2020.
- Invenomic Capital Management opened 64 new positions and closed 36 in Q1 2020.
- Invenomic Capital Management's portfolio value fell 51% quarter-over-quarter to $122M.
Based on Invenomic Capital Management's 13F filing for Q1 2020, filed 13 May 2020.